High-sensitivity C-reactive protein and parameters of left ventricular dysfunction

被引:70
作者
Shah, SJ [1 ]
Marcus, GM [1 ]
Gerber, IL [1 ]
McKeown, BH [1 ]
Vessey, JC [1 ]
Jordan, MV [1 ]
Huddleston, M [1 ]
Foster, E [1 ]
Chatterjee, K [1 ]
Michaels, AD [1 ]
机构
[1] Univ Calif San Francisco, Med Ctr, Dept Med, Div Cardiol, San Francisco, CA 94143 USA
关键词
C-reactive protein; heart failure; inflammation; left ventricular end-diastolic pressure; ejection fraction; cardiac catheterization; natriuretic peptides;
D O I
10.1016/j.cardfail.2005.08.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Elevated levels of high-sensitivity C-reactive protein (CRP), an inflammatory marker, have been associated with heart failure. However, it is not known which parameters of left ventricular dysfunction correlate with elevated levels of CRP. Methods and Results: In this cross-sectional study of 98 patients referred for cardiac catheterization, we investigated whether commonly used clinical indices of left ventricular dysfunction correlated with CRP levels. CRY levels were elevated to a greater degree in participants with diabetes mellitus (P =.006) and heart failure (P =.003). Increased CRP levels were associated with increased plasma levels of B-type natriuretic peptide (BNP; P =.0001), decreased left ventricular ejection fraction (LVEF; P =.02), and increased left-ventricular end-diastolic pressure (LVEDP; P =.0005). After multivariable adjustment, LVEDP and CRP were independently associated (P =.046). Conclusion: CRP is increased in patients with heart failure. Of the clinical parameters of left ventricular dysfunction, direct measurement of left ventricular end-diastolic pressure is most closely associated with CRP.
引用
收藏
页码:61 / 65
页数:5
相关论文
共 35 条
[1]   C-reactive protein as a predictor of improvement and readmission in heart failure [J].
Alonso-Martínez, JL ;
Llorente-Diez, B ;
Echegaray-Agara, M ;
Olaz-Preciado, F ;
Urbieta-Echezarreta, M ;
González-Arencibia, C .
EUROPEAN JOURNAL OF HEART FAILURE, 2002, 4 (03) :331-336
[2]   Role of C-reactive protein in cardiovascular disease [J].
Backes, JM ;
Howard, PA ;
Moriarty, PM .
ANNALS OF PHARMACOTHERAPY, 2004, 38 (01) :110-118
[3]  
Beranek JT, 1997, EUR HEART J, V18, P1834
[4]   C-Reactive protein in acute myocardial infarction: Association with heart failure [J].
Berton, G ;
Cordiano, R ;
Palmieri, R ;
Pianca, S ;
Pagliara, V ;
Palatini, P .
AMERICAN HEART JOURNAL, 2003, 145 (06) :1094-+
[5]   Inflammatory markers and onset of cardiovascular events - Results from the Health ABC study [J].
Cesari, M ;
Penninx, BWJH ;
Newman, AB ;
Kritchevsky, SB ;
Nicklas, BJ ;
Sutton-Tyrrell, K ;
Rubin, SM ;
Ding, JZ ;
Simonsick, EM ;
Harris, TB ;
Pahor, M .
CIRCULATION, 2003, 108 (19) :2317-2322
[6]   Usefulness of C-reactive protein as an independent predictor of death in patients with ischemic cardiomyopathy [J].
Chirinos, JA ;
Zambrano, JP ;
Chakko, S ;
Schob, A ;
Veerani, A ;
Perez, GO ;
Mendez, AJ .
AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (01) :88-90
[7]   Serum complement activation in congestive heart failure [J].
Clark, DJ ;
Cleman, MW ;
Pfau, SE ;
Rollins, SA ;
Ramahi, TM ;
Mayer, C ;
Caulin-Glaser, T ;
Daher, E ;
Kosiborod, M ;
Bell, L ;
Setaro, JF .
AMERICAN HEART JOURNAL, 2001, 141 (04) :684-690
[8]   TUMOR-NECROSIS-FACTOR SOLUBLE RECEPTORS IN PATIENTS WITH VARIOUS DEGREES OF CONGESTIVE-HEART-FAILURE [J].
FERRARI, R ;
BACHETTI, T ;
CONFORTINI, R ;
OPASICH, C ;
FEBO, O ;
CORTI, A ;
CASSANI, G ;
VISIOLI, O .
CIRCULATION, 1995, 92 (06) :1479-1486
[9]  
Fonarow G C, 2001, Rev Cardiovasc Med, V2 Suppl 2, pS7
[10]   Predictors of congestive heart failure in the elderly: The cardiovascular health study [J].
Gottdiener, JS ;
Arnold, AM ;
Aurigemma, GP ;
Polak, JF ;
Tracy, RP ;
Kitzman, DW ;
Gardin, JM ;
Rutledge, JE ;
Boineau, RC .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (06) :1628-1637